We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AABA
976
DELISTED
Altaba Inc
AABA
$838K 0.01%
12,082
-510
-4% -$35.7K
URI icon
977
United Rentals
URI
$70.2B
$837K 0.01%
+6,311
New +$801K
GBL
978
DELISTED
GAMCO Investors, Inc.
GBL
$835K 0.01%
43,540
+30,729
+240% +$605K
HBIO icon
979
Harvard Bioscience
HBIO
$27M
$826K 0.01%
41,285
+32,631
+377% +$956K
MMI icon
980
Marcus & Millichap
MMI
$1.18B
$808K 0.01%
26,189
-16,970
-39% -$616K
EZPW icon
981
Ezcorp Inc
EZPW
$1.87B
$803K 0.01%
+84,806
New +$826K
SASR
982
DELISTED
Sandy Spring Bancorp Inc
SASR
$798K 0.01%
+22,868
New +$769K
AMP icon
983
Ameriprise Financial
AMP
$47.6B
$792K 0.01%
5,459
-87,045
-94% -$12.6M
HCA icon
984
HCA Healthcare
HCA
$86.4B
$789K 0.01%
+5,834
New +$738K
STBA icon
985
S&T Bancorp
STBA
$1.88B
$788K 0.01%
+21,017
New +$815K
CCI icon
986
Crown Castle
CCI
$32.4B
$787K 0.01%
6,039
+5,115
+554% +$658K
CYBE
987
DELISTED
Cyberoptics Corp
CYBE
$786K 0.01%
48,457
+31,956
+194% +$538K
GNW icon
988
Genworth Financial
GNW
$3.79B
$783K 0.01%
+211,098
New +$748K
ZNGA
989
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$781K 0.01%
+127,342
New +$750K
ATKR icon
990
Atkore
ATKR
$2.54B
$780K 0.01%
30,142
-1,460
-5% -$35.7K
CLLS
991
Cellectis
CLLS
$291M
$772K 0.01%
+49,484
New +$884K
ECHO
992
DELISTED
Echo Global Logistics, Inc.
ECHO
$771K 0.01%
36,931
-32,949
-47% -$731K
CRK icon
993
Comstock Resources
CRK
$3.82B
$767K 0.01%
+137,751
New +$800K
SIMO icon
994
Silicon Motion
SIMO
$8.29B
$762K 0.01%
17,173
-80,995
-83% -$3.25M
CVI icon
995
CVR Energy
CVI
$3.43B
$760K 0.01%
15,202
-1,055
-6% -$47.3K
WRK
996
DELISTED
WestRock Company
WRK
$758K 0.01%
20,770
+4,301
+26% +$158K
MBIN icon
997
Merchants Bancorp
MBIN
$2.22B
$752K 0.01%
+66,227
New +$908K
CDR
998
DELISTED
Cedar Realty Trust, Inc
CDR
$747K 0.01%
42,692
-75,026
-64% -$1.5M
VCRA
999
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$737K 0.01%
+23,068
New +$736K
AAXJ icon
1000
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.66B
$733K 0.01%
+10,497
New +$729K

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.